Pregnant women with thalassemia syndrome usually
suffer from anemia with Hb levels of 7–10 g/dl and variable
degrees of splenomegaly [2, 3]. Consequent hypoxia and
massive tissue iron deposition may lead to concomitant cardiac,
hepatic, and endocrine system failure [4]. The physiologic
changes during pregnancy will further increase the
severity of anemia in the mother, which could aVect pregnancy
outcome as well as clinical symptoms [5]. These
pregnancies may be associated with a high rate of obstetric
complications, especially intrauterine fetal growth restriction